Njeri Gikenye

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Glioblastoma multiforme (GBM) has a poor prognosis despite maximal multimodal therapy. Biomarkers of relevance to prognosis which may also identify treatment targets are needed. A few hundred genetic(More)
  • 1